Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 121

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 121
---
 purchase
Common Shares from conditional capital available for new shareholders. The warrants are exercised by filing the appropriate exercise notice
with the Company according to the terms of the warrants and paying the exercise price, all within the exercise period. As a result the
Common Shares are automatically issued to the holder exercising its warrants.

The Company may issue further
warrants to purchase Common Shares. The Company may issue warrants independently or together with any other securities offered by any
prospectus supplement and the warrants may be attached to or separate from those securities. We will evidence each series of warrants
by warrant certificates that we may issue under a separate agreement or other evidence. Any series of warrants may be issued under a separate
warrant agreement, which may be entered into between us and a warrant agent specified in an applicable prospectus supplement relating
to a particular series of warrants. Any such warrant agent will act solely as our agent in connection with the warrants of such series
and will not assume any obligation or relationship of agency or trust with any of the holders of the warrants. We may also choose to act
as our own warrant agent. We will set forth further terms of the warrants and any applicable warrant agreements in the applicable prospectus
supplement relating to the issuance of any warrants, including, where applicable, the following:

| ● | the                    
 title of the warrants; |

| ● | the                               
 aggregate number of the warrants; |

| ● | exchange                                      
 distributions and/or secondary distributions; |

<div align='center'>81</div>

| ● | the                                                             
 number of securities purchasable upon exercise of the warrants; |

| ● | the                                                                                                                                  
 designation and terms of the securities, if any, with which the warrants are issued, and the number of the warrants issued with each 
 such offered security;                                                                                                               |

| ● | the                                                                                                       
 date, if any, on and after which the warrants and the related securities will be separately transferable; |

| ● | the                                                                                                                            
 price at which, and form of consideration for which, each security purchasable upon exercise of the warrants may be purchased; |

| ● | the                                                                                                         
 date on which the right to exercise the warrants will commence and the date on which the right will expire; |

| ● | if                                                                                                                
 applicable, the date on and after which such warrants and the related securities will be separately transferable; |

| ● | the                                                                                    
 manner in which the warrants may be exercised, which may include by cashless exercise; |

| ●